Erie County Medical Center

Buffalo, New York 14215

3 studies enrolling now · 53 studies all time

What they study most

ABSSSI, Acute Myocardial Infarction, Alcohol Abuse, Alcohol Dependence, Anastomosis, Surgical, Anemia, Anhedonia, Antibody-Mediated Graft Rejection, Asthma, BK Virus Infection, BK Virus Nephropathy, Bacteremia

Studies at this site

• A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons — Recruiting now
• A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) — Recruiting now
• A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia — Running, not enrolling
• Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension — Running, not enrolling
• The Acute Burn ResUscitation Multicenter Prospective Trial — Completed
• Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication — Completed
• A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Stopped early
• ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function — Running, not enrolling
• A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy — Completed
• Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) — Stopped early
• Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia — Enrolling by invitation
• A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial — Completed
• 24 Hour Ambulatory Cardiac Oxygen Consumption — Completed
• Evaluating LP-10 in Subjects With OLP — Status unconfirmed
• A Central Preservation and Assessment Service to Optimize Donor Kidney Allocation — Running, not enrolling
• Weight Management Program for Patients With First Episode Psychosis — Completed
• A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises — Stopped early
• Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients — Completed
• Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients — Completed
• The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) — Running, not enrolling
• Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia — Completed
• Maintaining Optimal Trauma Outcomes: Resilience in the Midst of a Ransomware Attack — Completed
• A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral Mucositis — Completed
• Kidney Paired Donation Video-Based Education Trial — Completed
• Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry — Status unconfirmed
• DePuy Trochanteric (ATN) Nailing Clinical Outcomes Trial — Completed
• TruGraf® Long-term Clinical Outcomes Study — Status unconfirmed
• A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure — Completed
• Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril — Completed
• StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood — Stopped early
• Regimen Optimization Study — Completed
• Facilitating Aftercare for Alcohol Detox Patients — Completed
• Cell-based Assays for Antibody-mediated Transplant Rejection — Status unconfirmed
• QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant — Completed
• Examining Heart Attacks in Young Women — Completed
• Living Donation and Kidney Transplantation Information — Completed
• Repeat Emergency Department Visits Among Patients With Asthma and COPD — Stopped early
• T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays — Completed
• 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension — Completed
• A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting — Completed
• Implementation of Practice Standards for ECG Monitoring — Completed
• Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) — Completed
• Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 — Stopped early
• S-100B as Pre-Head CT Scan Screening Test After Mild Traumatic Brain Injury — Completed
• A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study — Completed
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
• Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline — Status unconfirmed
• Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients — Completed
• Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia — Completed
• Buprenorphine as a Treatment in Opiate Dependent Pain Patients — Stopped early